Skip to main content
. Author manuscript; available in PMC: 2013 Mar 6.
Published in final edited form as: Neurogastroenterol Motil. 2011 Dec 12;24(3):229–e106. doi: 10.1111/j.1365-2982.2011.01845.x

Table 1. Demographic Characteristics in subjects with gastroesophageal reflux (GER) alone, dyspepsia alone, or dyspepsia-GER overlap.

Dyspepsia-GER Overlap (n=144) GER alone (n=260) Dyspepsia alone (n=200) Neither GER nor Dyspepsia (n=2913)
Age, mean (± SD) 58 ± 16 59 ± 16 60 ± 17 61 ± 15
Female (n=1909) 103 (72%) 149 (57%) 141 (71%) 1516 (52%)
Male gender (n=1608) 41 (28%) 111 (43%) 59 (29%) 1397 (48%)
SSC score, mean (SD) 1.5 ± 0.9 1.0 ± 0.7 1.2 ± 0.7 0.7 ± 0.6
Visiting a physician > 5 times (n=369) 35 (24%) 43 (17%) 42 (21%) 249 (9%)
Medication
 PPIs (n=708) 80 (56%) 109 (42%) 69 (35%) 450 (16%)
 Calcium channel blockers (n=204) 11 (8%) 12 (5%) 16 (8%) 165 (6%)
 Antidepressants (n=514) 40 (29%) 48 (19%) 57 (29%) 369 (13%)
 Narcotics (n=413) 34 (24%) 42 (16%) 39 (20%) 298 (10%)
 Antispasmodics (n=54) 11 (8%) 7 (3%) 9 (5%) 27 (1%)
IBS (n=683) 81 (56%) 82 (32%) 102 (51%) 418 (14%)
Somatic symptom checklist items
 Headaches, mean (± SD) 1.4 ± 1.2 0.9 ± 1.0 1.0 ± 1.1 0.6 ± 0.8
 Backaches, mean (± SD) 1.9 ± 1.3 1.4 ± 1.2 1.7 ± 1.3 1.0 ± 1.1
 Insomnia, mean (± SD) 2.0 ± 1.3 1.3 ± 1.1 1.5 ± 1.2 0.9 ± 1.0
 General stiffness, mean (± SD) 1.9 ± 1.4 1.7 ± 1.2 1.8 ± 1.3 1.1 ± 1.1
 Dizziness, mean (± SD) 1.0 ± 1.2 0.5 ± 0.9 0.6 ± 0.9 0.3 ± 0.6
 Weakness, mean (± SD) 1.0 ± 1.3 0.5 ± 1.0 0.8 ± 1.1 0.3 ± 0.7

SSC, somatic symptom checklist; PPI, proton pump inhibitors; IBS, irritable bowel syndrome